title: The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease.
abstract: There is a need for treatment options in patients with type 2 diabetes mellitus and kidney disease to achieve glucose targets without risk of hypoglycemia. This article describes management options for these patients using glucose-lowering therapies, in particular dipeptidyl peptidase-4 inhibitors.
authors.affiliation: Polly A. Bittle is an NP, practice manager, chief operating officer, and clinical research director at Tampa Bay Nephrology Associates, Tampa, Fla.
authors.forename: Polly A
authors.initials: PA
authors.lastname: Bittle
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000451:nursing; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007003:Hypoglycemia / Q000517:prevention & control; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000451:nursing
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors